Chemodectoma, carotid artery paraganglioma (tumor in the carotid artery) in Dogs

Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

A chemodectoma, also known as a carotid artery paraganglioma, is a rare, usually benign tumor that arises from the chemoreceptors of the carotid artery (Arteria carotis). These tumors can compress surrounding tissue and often lead to clinical symptoms due to their location and size.

The most important facts at a glance

A chemodectoma, also known as a carotid artery paraganglioma, is a tumor that arises from the chemoreceptors in the carotid artery of dogs. These receptors are responsible for regulating breathing by reacting to changes in blood chemistry. The exact cause of the tumor is not fully understood, but genetic factors play a role, as certain breeds like Boxers and Boston Terriers are more frequently affected. Environmental factors leading to chronic oxygen deficiency could also be involved.

Symptoms of a chemodectoma can include Respiratory distress, Congestive heart failure, Cough, and reduced exercise tolerance. For diagnosis, a thorough examination is performed, supplemented by imaging techniques such as ultrasound, CT, or MRI. A biopsy may be necessary to determine the type of tumor. Therapy depends on the tumor size and the dog’s health; surgical removal of the tumor is often the goal. In cases where surgery is not possible, palliative therapy can be provided.

The prognosis varies depending on the tumor type and treatment method. Regular follow-up examinations are important to monitor for tumor regrowth. Since the exact causes are not fully known, there are no specific prevention measures. However, regular veterinary check-ups and avoiding environmental factors that could cause chronic hypoxia are recommended.

Causes

The arteria carotis is a main artery in the neck that supplies the brain with blood. At its origin are chemoreceptors that respond to changes in blood chemistry, such as oxygen and carbon dioxide concentrations. These chemoreceptors are part of the so-called carotid body, which plays an important role in the regulation of breathing.

A chemodectoma arises from the chief cells of these chemoreceptors. The exact cause of a chemodectoma is not fully understood. However, it is believed that genetic factors may play a role, as certain dog breeds are more prone to developing these tumors. Otherwise, there is evidence that environmental factors leading to chronic hypoxia might also play a role.

In dogs, certain breeds such as the Boxer and Boston Terrier are more frequently affected. This suggests a genetic predisposition. It is suspected that these breeds may have genetic mutations that increase the risk of tumor formation.

Symptoms

The symptoms of a chemodectoma vary depending on the size and location of the tumor. In the early stages of the disease, there are often no obvious symptoms. However, as the tumor grows, signs may appear caused by the compression of surrounding structures.

The most common symptoms include Respiratory distress, which can result from pressure on the windpipe. Some dogs also show symptoms like a Cough or breathing noises. In advanced cases, difficulty swallowing may occur if the tumor affects the esophagus.

Another possible symptom is a Swelling in the neck area, which can be detected during physical examination. This Swelling can be painful and cause the animal to spare the affected area or avoid being touched.

Diagnosis

The diagnosis of a chemodectoma usually begins with a thorough clinical examination and a detailed medical history to identify previous symptoms or breed predispositions. Imaging techniques are crucial for diagnosis and assessing the tumor size and its relationship to surrounding structures.

Ultrasound examinations or X-rays can be used initially to identify a mass in the neck area. However, computed tomography (CT) or magnetic resonance imaging (MRI) provides a more detailed view of the tumor and its extent.

For a definitive diagnosis, a fine-needle aspiration or biopsy is often required to perform cytological or histological examinations. These procedures allow for confirmation of the tumor type and assessment of the cell structure to distinguish between benign and malignant tumors.

Therapy

The therapy for a chemodectoma depends on the size, location, and general health of your dog. In many cases, surgical removal of the tumor is considered, especially if the tumor is causing symptoms or if there is a risk of malignant growth.

However, surgical procedures can be complex because the tumor is located near vital structures like the carotid artery. Careful planning and execution by an experienced surgeon are crucial to minimize complications.

In some cases, primarily in older dogs or when the tumor is inoperable, palliative therapy may be considered. This can include administering medication to relieve symptoms or using radiation therapy to control tumor growth.

Prognosis and follow-up care

The prognosis for dogs with a chemodectoma varies depending on the size and aggressiveness of the tumor as well as the treatment method used. Benign tumors that can be completely removed surgically often have a better prognosis.

For malignant tumors or those that cannot be completely removed due to their location, the prognosis may be more guarded. Quality of life and life expectancy can be improved through palliative measures, but the long-term outlook is often uncertain.

Regular follow-up examinations are crucial to monitor for any tumor regrowth and to take further treatment measures if necessary.

Prevention

Since the exact causes of chemodectoma development are not fully understood, there are no specific measures for the prevention of these tumors. However, the genetic predisposition in certain breeds means that breeding animals should be selected carefully to minimize the risk. Regular veterinary check-ups are important to detect signs of a chemodectoma or other health problems early on. Early diagnosis and intervention can significantly improve the prognosis. Avoiding environmental factors that could cause chronic hypoxia, such as smoking near pets or living in highly polluted areas, could theoretically reduce the risk, although this has not been specifically proven.

Outlook on current research

In the case of chemodectoma (paraganglioma of the aortic or carotid body; “heart base tumor”), research mainly focuses on earlier detection and gentler therapy. Imaging is becoming more precise: high-resolution heart ultrasound, CT/MRI, and 3D reconstructions help to better visualize the size, location relative to the aorta/heart, and possible narrowing of the airway or esophagus. This allows for more individualized procedures and radiation therapy plans. Radiation therapy is particularly important: fractionated or stereotactic procedures are being developed to target the tumor precisely while sparing surrounding tissue. In terms of medication, researchers are testing whether targeted agents (e.g., tyrosine kinase inhibitors or anti-angiogenic therapies) can slow growth when surgery or radiation therapy is not enough. At the same time, researchers are looking for risk factors: Why are brachycephalic breeds more frequently affected? What role does chronic oxygen deficiency play? Genetic markers and measurements of oxygen supply could help with prevention in the future. For dogs with pericardial effusion, minimally invasive relief and better-planned follow-up intervals are being evaluated so that shortness of breath and collapse occur less frequently. The goal is a combination of early diagnosis, safe local control, and good quality of life – especially for older dogs where major surgery is often not an option.

Frequently asked questions (FAQs)